- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05967221
Comparison of Postoperative Analgesia Between Intravenous Paracetamol and Intranasal Tapentadol
'A Comparative Study Between Intranasal Tapentadol Versus Intravenous Paracetamol for Post-operative Analgesia in Lower Limb Orthopedic Surgeries Under Spinal Anaesthesia'
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Inclusion criteria Age: From 18.00 Year(s) to 60.00 years Gender: Both American Society of Anesthesiologists (ASA) physical status: 1 & 2, posted for elective lower limb orthopedic surgeries
Exclusion criteria
- Sepsis at the site of injection
- Coagulopathy
- Patients with history of renal, hepatic, cardiovascular disease
- Patient on chronic opioid use
Outcome Comparing postoperative analgesia between the groups every 12 hours after the intervention till about 72 hours post intervention.
The secondary outcome is to compare the need for the rescue analgesia between the groups
Study Type
Enrollment (Actual)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
Karnataka
-
Bangalore, Karnataka, India, 560004
- Kempegowda Institute of Medical Sciences
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria: 1. American Society of Anesthesiologists (ASA) physical status 1 & 2 2. Posted for elective lower limb orthopaedic surgeries
Exclusion Criteria:
- Sepsis at the site of injection
- Coagulopathy
- Patients with history of renal, hepatic, cardiovascular disease
- Patient on chronic opioid use -
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Tapentadol
Tapentadol is a novel, centrally acting analgesic with dual mechanism of action, combining mu-opioid receptor agonism with norepinephrine reuptake inhibition.this
dual mode of action is responsible for its opioid sparing effect, which contributes to reduction in some of the typical opioid related adverse effects
|
Intranasal administration of tapentadol would be compared with intravenous paracetamol for postoperative analgesia
|
Active Comparator: Paracetamol
Paracetamol is one of the most frequently used analgesic and antipyretic agent, interferes neither with platelet nor kidney functions nor does it present the unwanted side effects of NSAIDS.
|
Paracetamol
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pain as measured with Visual analogue scale
Time Frame: Every 12 hours after the intervention till about 72 hours after the intervention
|
The pain rating was done as per a visual analogue scale (VAS) of 0-10 (score 0 = no pain, score 10 - most severe pain).
Patients with a VAS score of more than 3, at what is considered as base line, in group A=received IV paracetamol 1gm given every 5-6 hourly and in group B=received intranasal tapentadol 44.5mg nasal spray administered every 5-6 hourly.
Patient was assessed for pain by using VAS half an hour after administration and the scores were documented.
Pain score were recorded at and after 30 minutes of the intervention in the following time frames - 12hr,24hr,36hr,48hr, 60hr and 72hrs after the baseline intervention (0hr).
|
Every 12 hours after the intervention till about 72 hours after the intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The need for rescue analgesia
Time Frame: In the first 72 hours after the initiation of the intervention
|
The need for the add on analgesic whenever the subjects request for the same
|
In the first 72 hours after the initiation of the intervention
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Physiological Effects of Drugs
- Adrenergic Agents
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Analgesics
- Sensory System Agents
- Analgesics, Non-Narcotic
- Antipyretics
- Analgesics, Opioid
- Narcotics
- Neurotransmitter Uptake Inhibitors
- Membrane Transport Modulators
- Adrenergic Uptake Inhibitors
- Acetaminophen
- Tapentadol
Other Study ID Numbers
- KIMS/IEC/A035/D/2021
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lower Limb Fracture
-
Armed Police Force Hospital, NepalNepal Orthopedic Hospital, Kathmandu, NepalNot yet recruiting
-
University of CalgaryAlberta Health services; Canadian Academy of Sport & Exercise MedicineNot yet recruitingLower Limb Fracture | Lower Limb; Sprain (Strain)
-
Hospital Clínico Universitario de ValladolidHospital Clinic of Barcelona; Hospital de Basurto; Complejo Hospitalario de Navarra and other collaboratorsRecruitingPeriprosthetic Fractures | Periprosthetic Fracture of the Upper or Lower Limb | Peri-implant Fracture of the Upper or Lower Limb | Peri-implant FractureSpain
-
Zagazig UniversityEnrolling by invitation
-
Kempegowda Institute of Medical Sciences, BangaloreCompletedLower Limb FractureIndia
-
EpicentreBrown University; Medecins Sans Frontieres, NetherlandsWithdrawnFracture | Lower Limb Injuries
-
University of WashingtonUnited States Department of DefenseRecruitingLower Limb; Fusion, Congenital | Lower Limb Fracture | Ankle Foot InjuryUnited States
-
Cristália Produtos Químicos Farmacêuticos Ltda.Irmandade da Santa Casa de Misericordia de Sao Paulo; Serviço Social da Indústria...WithdrawnFracture of Lower LimbBrazil
-
China International Neuroscience InstitutionCompleted
-
University of Witten/HerdeckeUnknownLower Limb FracturesGermany
Clinical Trials on Paracetamol
-
GlaxoSmithKlineCompleted
-
University of HelsinkiFoundation for Paediatric Research, FinlandCompleted
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompletedHealthy SubjectsUnited States
-
Kamuzu University of Health SciencesCompleted
-
Baxter Healthcare CorporationCompletedPain, PostoperativeUnited Kingdom
-
Bangabandhu Sheikh Mujib Medical University, Dhaka...CompletedDiurnal Variation of Paracetamol ExcretionBangladesh
-
GlaxoSmithKlineCompleted